Abstract
A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1°C. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not suspected. Since he was in good overall health and no concomitant symptoms and signs were apparent, we considered it to be drug fever due to favipiravir. After the completion of favipiravir treatment, the patient’s temperature normalized within 24 hours. We herein report this case of drug fever caused by favipiravir.
Keywords: COVID-19; drug fever; favipiravir; hyperuricemia.
All Keywords
【저자키워드】 COVID-19, Favipiravir, drug fever, hyperuricemia., 【초록키워드】 Treatment, coronavirus disease, Coronavirus disease 2019, Hospitalized, Favipiravir, Symptom, novel coronavirus disease, drug fever, Novel coronavirus, Health, Fever, temperature, Japanese, bradycardia, administration, 24 hours, Hyperuricemia, Pulse rate, completion, caused, the patient, elevated, bpm, normalized, 【제목키워드】 Favipiravir, drug, drug fever,
【저자키워드】 COVID-19, Favipiravir, drug fever, hyperuricemia., 【초록키워드】 Treatment, coronavirus disease, Coronavirus disease 2019, Hospitalized, Favipiravir, Symptom, novel coronavirus disease, drug fever, Novel coronavirus, Health, Fever, temperature, Japanese, bradycardia, administration, 24 hours, Hyperuricemia, Pulse rate, completion, caused, the patient, elevated, bpm, normalized, 【제목키워드】 Favipiravir, drug, drug fever,
{{{ 추상적인 }}}
55세 일본 남성이 신종 코로나바이러스 감염증(코로나19) 2019(COVID-19)로 입원했습니다. 파비피라비르 투여 시작 후 14일째 환자는 38.1°C의 발열을 보였다. 맥박도 128bpm으로 높아져 상대적 서맥은 의심되지 않았다. 전반적인 건강 상태가 양호했고 수반되는 증상 및 징후가 없었기 때문에 파비피라비르로 인한 약물 열병으로 간주했습니다. 파비피라비르 치료 완료 후 환자의 체온은 24시간 이내에 정상화되었습니다. 우리는 favipiravir에 의한 약물 열병의 사례를 보고합니다.
{{ 키워드: }} 코로나19; 약물 발열; 파비피라비르; 고요산혈증.